ESPR - Esperion Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ESPR is currently covered by 8 analysts with an average price target of $13.45. This is a potential upside of $12.22 (993.5%) from yesterday's end of day stock price of $1.23.

Esperion Therapeutics's activity chart (see below) currently has 210 price targets and 190 ratings on display. The stock rating distribution of ESPR is 86.11% BUY, 8.33% HOLD and 5.56% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.98% with an average time for these price targets to be met of 123.82 days.

Highest price target for ESPR is $16, Lowest price target is $2.5, average price target is $6.08.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 20-Mar-2025. First documented stock forecast 27-Oct-2014.

Currently out of the existing stock ratings of ESPR, 31 are a BUY (86.11%), 3 are a HOLD (8.33%), 2 are a SELL (5.56%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$16

$14.5 (966.67%)

$16

15 days ago
(20-Mar-2025)

0/4 (0%)

$14.38 (887.65%)

Buy

$4

$2.5 (166.67%)

30 days ago
(05-Mar-2025)

1/12 (8.33%)

$2.35 (142.42%)

255

Buy

$4

$2.5 (166.67%)

$7

1 months 24 days ago
(11-Feb-2025)

0/3 (0%)

$2.21 (123.46%)

Hold

$4

$2.5 (166.67%)

$3.5

3 months 17 days ago
(18-Dec-2024)

8/9 (88.89%)

$1.84 (85.19%)

79

Buy

$6

$4.5 (300.00%)

$6

3 months 22 days ago
(13-Dec-2024)

0/10 (0%)

$3.75 (166.67%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ESPR (Esperion Therapeutics) average time for price targets to be met?

On average it took 123.82 days on average for the stock forecasts to be realized with a an average price target met ratio 39.98

Which analyst has the current highest performing score on ESPR (Esperion Therapeutics) with a proven track record?

JOEL BEATTY

Which analyst has the most public recommendations on ESPR (Esperion Therapeutics)?

Joel Beatty works at BAIRD and has 9 price targets and 3 ratings on ESPR

Which analyst is the currently most bullish on ESPR (Esperion Therapeutics)?

Alex Schwartz with highest potential upside - $92.5

Which analyst is the currently most reserved on ESPR (Esperion Therapeutics)?

Martin Auster with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?